Relmada Therapeutics, a clinical-stage biotech company developing therapies for cancer and CNS disorders, announced its CEO and CFO will participate in the Jefferies Global Healthcare Conference in London from November 16 to 19, 2026. The event includes a fireside chat and one-on-one investor meetings, with a webcast available on Relmada's investor website. This participation highlights Relmada's ongoing efforts to engage with investors and showcase its clinical progress, particularly for its lead drug candidates NDV-01 and sepranolone.
Relmada Therapeutics' participation at the Jefferies Global Healthcare Conference in London provides context for health-sector market activity. For readers following health stocks, here is Pluang's market snapshot as of Nov 04, 2026 18:41 WIB: out of 150 priced US health-sector stocks, 118 rose and 24 fell. Notable movers include Canopy Growth Corp (CGC) at USD 0.75 with a 6.13% increase and 100% buy order activity, Tilray Brands Inc (TLRY) at USD 2.81 with a 6.04% rise and mostly sell orders, and Inovio Pharmaceuticals Inc (INO) at USD 1.76 with a 6.02% gain and a nearly balanced buy-sell order split.
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
Dimensional Fund Advisors Ltd. filed a Form 8.3 disclosure revealing it holds a 1.27% stake in Prologis Inc as of November 3, 2026. This disclosure is part of regulatory requirements under the Takeover Code for investors holding 1% or more in relevan...
Dimensional Fund Advisors Ltd. has disclosed an interest in 1,516,595 ordinary shares of DCC Energy plc, representing 1.78% of the company's shares as of November 3, 2026. The disclosure follows regulatory requirements under the Irish Takeover Panel ...
Wayfair reported Q3 2026 net revenue of $3.4 billion, up 9.7% year-over-year, driven by an 11.4% increase in U.S. revenue. Active customers grew 4.7% to 22.2 million, with orders up 12.2%, signaling strong market share gains. The company posted a net...
